PET Scanners Market Size & Growth Forecast 2027–2036, By Segments (Modality, Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
PET Scanners Market size was valued at USD 2.9 billion in 2026 and is anticipated to grow at a 3.52% CAGR from 2027 to 2036, surpassing USD 4.1 billion by 2036. The industry revenue for 2027 is estimated at USD 2.99 billion.
Get more details on this report
Request Free Sample ReportPET Scanners Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 36.16% of the market in 2026, supported by advanced imaging infrastructure, strong PET utilization, mature procurement channels, and steady equipment replacement demand.
- Asia Pacific is expected to grow at a 4.33% CAGR, driven by expanding healthcare infrastructure, greater investment in diagnostic imaging, and broader adoption of PET scanners across clinical settings.
Segment Momentum
- PET-CT accounted for 77.81% of the market in 2026 by combining metabolic and anatomical imaging within one workflow, supporting confident diagnosis, treatment planning, and routine clinical use.
- Cardiology is growing the fastest as providers increasingly require precise non-invasive cardiac imaging for myocardial assessment and treatment planning in complex cardiovascular cases.
Market Expansion Drivers
- Rising cancer prevalence driving demand for advanced diagnostic imaging.
- Technological advancements in PET-CT improving diagnostic accuracy and efficiency.
- Increasing adoption of radiopharmaceuticals and targeted tracers in molecular imaging.
Leading Market Participants
- Top players in the PET scanners market include Siemens Healthineers AG (Germany), GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Shimadzu Corporation (Japan), Mediso Ltd. (Hungary), Positron Corporation (United States), PerkinElmer, Inc. (United States), United Imaging Healthcare Co., Ltd. (China), Bruker Corporation (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.9 billion
- 2027 Estimated Market Size: USD 2.99 billion.
- Projected Market Size: USD 4.1 billion by 2036
- Growth Forecast: 3.52% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: PET-CT (Modality) | Oncology (Application) | Hospitals (End Use)
- Emerging Opportunity Segment: PET-CT (Modality) | Cardiology (Application) | Diagnostic Imaging Centers (End Use)
Market Growth Drivers and Industry Trends
Rising cancer prevalence driving demand for advanced diagnostic imaging
The PET scanners market is gaining momentum as rising cancer prevalence increases the need for advanced diagnostic imaging capable of supporting disease detection and evaluation. PET imaging provides clinicians with molecular and functional information that complements conventional diagnostic approaches, encouraging healthcare facilities to strengthen imaging capabilities for oncology-related assessment and patient management.
Technological advancements in PET-CT improving diagnostic accuracy and efficiency
Advances in PET-CT technology are improving the integration of metabolic and anatomical imaging, strengthening diagnostic workflows. For the PET scanners market, enhanced imaging capabilities can support more precise interpretation while improving operational efficiency, making technologically advanced systems increasingly relevant to healthcare providers seeking improved diagnostic performance.
Increasing adoption of radiopharmaceuticals and targeted tracers in molecular imaging
Growing use of radiopharmaceuticals and targeted tracers is broadening the clinical utility of molecular imaging. This trend supports the PET scanners market by increasing demand for imaging systems capable of working with tracer-based diagnostic approaches, particularly where clinicians require functional information to assess biological processes and disease characteristics.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cancer prevalence driving demand for advanced diagnostic imaging | 2.00% | High | North America, Europe | High | Near Term |
| Technological advancements in PET-CT improving diagnostic accuracy and efficiency | 1.80% | High | Global | High | Mid Term |
| Increasing adoption of radiopharmaceuticals and targeted tracers in molecular imaging | 1.70% | High | North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the PET scanners market at 36.16% in 2026, underpinned by advanced diagnostic infrastructure, strong adoption of nuclear medicine technologies, and substantial demand for sophisticated imaging in oncology, cardiology, and neurological care. The region benefits from well-established healthcare systems and continued investment in upgrading imaging capabilities, while growing emphasis on early and precise disease detection is supporting the integration of PET imaging into clinical workflows. Demand is further reinforced by the increasing use of hybrid imaging technologies and the need for more effective monitoring of treatment response, particularly in complex and chronic diseases.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing region, driven by expanding healthcare infrastructure, improving access to advanced diagnostic services, and increasing investment in medical imaging capabilities. Rising healthcare expenditure and greater awareness of early disease diagnosis are encouraging hospitals and diagnostic centers to adopt advanced PET-based technologies. The expansion of specialized cancer-care facilities and improvements in healthcare delivery across developing markets are also broadening the addressable patient base. In addition, technological advancements that improve imaging efficiency and diagnostic precision are supporting wider adoption, positioning Asia Pacific as a key growth market for PET scanners.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Imaging FocusGermany emphasizes high-performance PET scanners for specialized diagnostic centers and university hospitals. The country supports investments in imaging systems that enhance quantitative analysis, operational efficiency, and integration with advanced radiology and nuclear medicine workflows.
France 🇫🇷
Hospital Modernization DriveFrance continues upgrading PET scanner capabilities within public and regional healthcare facilities to improve diagnostic access. Procurement decisions increasingly favor systems offering operational efficiency, lower maintenance requirements, and advanced imaging performance.
Italy 🇮🇹
Regional Diagnostic ExpansionItaly focuses on expanding PET scanner availability across regional healthcare networks while modernizing existing imaging infrastructure. Buyers seek versatile systems that improve diagnostic consistency and support multidisciplinary clinical applications.
Japan 🇯🇵
Aging Care ImagingJapan expands PET scanner utilization to address growing diagnostic requirements associated with an aging population. Healthcare providers prioritize compact, reliable systems with enhanced image quality and efficient patient throughput for routine clinical practice.
South Korea 🇰🇷
Digital Imaging IntegrationSouth Korea strengthens PET scanner deployment through digitally connected hospitals and advanced diagnostic infrastructure. Market activity centers on AI-enabled image processing, streamlined clinical workflows, and compatibility with precision medicine initiatives.
United States 🇺🇸
Clinical Innovation HubThe U.S. continues to prioritize advanced PET scanner adoption across oncology, neurology, and cardiology, supported by integrated healthcare networks and ongoing imaging technology upgrades. Demand increasingly favors systems that improve diagnostic precision, workflow efficiency, and compatibility with hybrid imaging platforms.
Segment Leadership and Growth Trends
PET Scanners Market Share (%), by Modality, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportModality Segment Analysis: PET-CT (Largest & Fastest-Growing Segment)
PET-CT held the largest share of the PET scanners market in 2026, accounting for 77.81%, while also representing the fastest-growing modality. Its strong position is driven by the ability to combine functional information from positron emission tomography with detailed anatomical imaging from computed tomography, enabling more comprehensive disease assessment. PET-CT is particularly valuable where clinicians need to identify abnormal metabolic activity while accurately localizing lesions, supporting diagnosis, staging, treatment planning, and follow-up. Increasing demand for integrated diagnostic imaging and greater emphasis on precise clinical decision-making continue to strengthen adoption of this modality.
Application Segment Analysis: Oncology (Largest Segment) vs Cardiology (Fastest-Growing Segment)
Oncology dominated the PET scanners market in 2026, accounting for 49.82% of the market, reflecting the extensive role of PET imaging in cancer detection, staging, treatment planning, and response assessment. PET-based metabolic imaging provides clinicians with information that complements anatomical scans, helping identify active disease and evaluate changes during treatment. Growing emphasis on earlier and more precise cancer assessment, together with the increasing use of hybrid imaging, continues to support oncology as the leading application area.
Cardiology is emerging as the fastest-growing application segment as PET imaging gains greater relevance in the assessment of myocardial perfusion, viability, and cardiovascular disease. The ability to obtain functional information can assist clinicians in evaluating cardiac tissue and supporting treatment decisions, particularly when conventional anatomical assessment may provide limited insight. Increasing attention to early cardiovascular diagnosis and more personalized disease management is encouraging broader use of advanced metabolic imaging in cardiac care.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Modality | PET-CT, PET-MRI | PET-CT | PET-CT |
| Application | Oncology, Cardiology, Neurology | Oncology | Cardiology |
| End Use | Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes | Hospitals | Diagnostic Imaging Centers |
Competitive Landscape and Market Positioning
Major players in the PET scanners market:
1. Siemens Healthineers AG (Germany)
2. GE HealthCare Technologies Inc. (United States)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. Shimadzu Corporation (Japan)
6. Mediso Ltd. (Hungary)
7. Positron Corporation (United States)
8. PerkinElmer Inc. (United States)
9. United Imaging Healthcare Co. Ltd. (China)
10. Bruker Corporation (United States)
Diagnostic imaging advancements are accelerating evolution in the PET scanners market. Improved resolution and faster imaging processes are enhancing clinical decision-making. The PET scanners market is also experiencing growing demand due to rising adoption of precision diagnostics.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Siemens Healthineers AG (Germany) | |||||||
| GE HealthCare Technologies Inc. (United States) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| Shimadzu Corporation (Japan) | |||||||
| Mediso Ltd. (Hungary) | |||||||
| Positron Corporation (United States) | |||||||
| PerkinElmer Inc. (United States) | |||||||
| United Imaging Healthcare Co. Ltd. (China) | |||||||
| Bruker Corporation (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Sutter Health | Oct-25 | Sutter Health entered a seven-year, $1 billion agreement with GE HealthCare to modernize diagnostic imaging infrastructure across Northern California. This strategic partnership focuses on the large-scale deployment of AI-enabled technologies, facilitating the expansion of advanced imaging systems and enhancing operational workflow capabilities within the regional healthcare network. |
| Telix Pharmaceuticals | Oct-25 | Telix Pharmaceuticals commenced U.S. commercialization of Gozellix, its PET imaging agent for prostate cancer. By establishing distribution channels for this diagnostic agent, the company expands clinical access to targeted nuclear medicine applications, strengthening its competitive positioning in the specialized oncological imaging market. |
| Neurophet | Oct-25 | Neurophet signed an exclusive sales agreement with Lado Technology and initiated plans for a joint venture to facilitate entry into the Chinese market. This expansion strategy aims to scale the commercial reach of its AI-driven brain imaging solutions, integrating advanced neuro-imaging software into regional nuclear medicine workflows. |
| Siemens Healthineers | Oct-25 | Siemens Healthineers initiated a field corrective action for specific PET imaging systems following reports of potential image artifacts. This quality management intervention ensures the maintenance of clinical diagnostic standards and system reliability for the installed base of PET scanners, reflecting ongoing efforts to manage performance consistency in medical imaging operations. |
| Industry Development | Jun-24 | The clinical emergence of Augmented Whole-Body Scanning via Magnifying PET (AWSM-PET) represents a material technical advancement in PET/CT imaging. This innovation provides measurable improvements in system sensitivity and image clarity, enabling higher resolution whole-body diagnostic outcomes compared to traditional scanning methodologies, with potential for broader adoption in clinical oncological screening. |
| CDL Nuclear Technologies | Apr-24 | CDL Nuclear Technologies introduced a mobile cardiac PET/CT trailer, providing healthcare facilities with flexible access to specialized nuclear imaging services. This on-demand model addresses capital barriers to entry for advanced cardiac diagnostics, enabling medical centers to deploy high-resolution PET/CT capabilities without permanent on-site infrastructure investments. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
PET Scanners Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Procurement Model | Direct Capital Purchase, Leasing & Financing, Managed Equipment Services |
| Mobility | Fixed Systems, Mobile & Transportable Systems |
| Detector Technology | Photomultiplier Tube (PMT)-Based, Silicon Photomultiplier (SiPM)-Based, Hybrid Detector Systems |
PET Scanners Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Clinical Workflow Optimization Assessment |
|
| PET Imaging Infrastructure Expansion Study |
|
| Radiopharmaceutical Supply Ecosystem Analysis |
|
Need a different cut of the data?
Request Custom ResearchHow big is the PET scanners market?
How is the PET scanners industry projected to perform over the next decade?
How is oncology demand reshaping investment priorities in the PET scanners market?
Why are PET-CT technology advancements accelerating adoption among imaging providers?
Why does PET-CT dominate the PET scanners market?
Why is cardiology the fastest-growing application for PET scanners?
Why is North America the largest market for PET scanners?
What factors are accelerating PET scanner market growth in Asia Pacific?
Who are the major participants shaping the PET scanners landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization